Pharmaceuticals in Italy

Pharmaceuticals in Italy


  • Products Id :- OHMF4477
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Italy

Summary

Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Italy pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Italian pharmaceuticals market had total revenues of USD 26.1bn in 2017, representing a compound annual growth rate (CAGR) of 2.5% between 2013 and 2017.

- Unlike many of its Western European neighbors, Italy's brand-name market takes much more of the market than generics largely due to a lack of pro-generic policies and negative attitudes among physicians.

- In 2010 the Italian government reduced health expenditure by USD 22.2bn, causing a reduction in drug prices by 1.2%. As a result of continuing austerity measures, the use of generic drugs has taken on greater importance than has previously been the case.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Italy

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Italy

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Italy pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Italy pharmaceuticals market by value in 2017?

- What will be the size of the Italy pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Italy pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Italy's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 17

Threat of substitutes 19

Degree of rivalry 20

Leading Companies 22

Chiesi Farmaceutici SpA 22

Pfizer Inc. 24

Recordati S.p.A. 28

The Menarini Group 31

Macroeconomic Indicators 32

Country data 32

Methodology 34

Industry associations 35

Related MarketLine research 35

Appendix 36

About MarketLine 36

List of Figures

Figure 1: Italy pharmaceuticals market value: USD billion, 2013-17

Figure 2: Italy pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Italy pharmaceuticals market share: % share, by value, 2017

Figure 4: Italy pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Italy, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Italy, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Italy, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2017

Figure 11: Pfizer Inc.: revenues & profitability

Figure 12: Pfizer Inc.: assets & liabilities

Figure 13: Recordati S.p.A.: revenues & profitability

Figure 14: Recordati S.p.A.: assets & liabilities

List of Tables

Table 1: Italy pharmaceuticals market value: USD billion, 2013-17

Table 2: Italy pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Italy pharmaceuticals market share: % share, by value, 2017

Table 4: Italy pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Chiesi Farmaceutici SpA: key facts

Table 6: Pfizer Inc.: key facts

Table 7: Pfizer Inc.: key financials (USD )

Table 8: Pfizer Inc.: key financial ratios

Table 9: Recordati S.p.A.: key facts

Table 10: Recordati S.p.A.: key financials (USD )

Table 11: Recordati S.p.A.: key financials (EUR)

Table 12: Recordati S.p.A.: key financial ratios

Table 13: The Menarini Group: key facts

Table 14: Italy size of population (million), 2013-17

Table 15: Italy gdp (constant 2005 prices, USD billion), 2013-17

Table 16: Italy gdp (current prices, USD billion), 2013-17

Table 17: Italy inflation, 2013-17

Table 18: Italy consumer price index (absolute), 2013-17

Table 19: Italy exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24983
Site License
USD 700 INR 49966
Corporate User License
USD 1050 INR 74949

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com